IBO IMPACT BIOMEDICAL INC.

NYSE www.impactbiomedinc.com


$ 0.44 $ 0.00 (-0.45 %)    

Wednesday, 19-Nov-2025 15:36:35 EST
QQQ $ 599.93 $ 3.56 (0.6 %)
DIA $ 461.58 $ 0.46 (0.1 %)
SPY $ 662.83 $ 2.55 (0.39 %)
TLT $ 88.89 $ -0.18 (-0.2 %)
GLD $ 374.84 $ 0.61 (0.16 %)
$ 0.4391
$ 0.44
$ 0.42 x 100
$ 0.45 x 100
$ 0.44 - $ 0.44
$ 0.36 - $ 6.17
129,279
na
5.35M
$ 3.79
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-14-2025 06-30-2025 10-Q
3 05-14-2025 03-31-2025 10-Q
4 03-28-2025 12-31-2024 10-K
5 11-12-2024 09-30-2024 10-Q
6 08-13-2024 06-30-2024 10-Q
7 05-10-2024 03-31-2024 10-Q
8 02-20-2024 12-31-2023 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Impact BioMedical (AMEX:IBO) reported quarterly losses of $(1.18) per share. The company reported $7.00 thousand in sales this...

Core News & Articles

On July 21, 2025, Impact BioMedical Inc. (the "Company" or "Borrower") entered into a Debt Conversion Agreement...

 impact-biomedical-stock-is-soaring-monday-whats-going-on

Impact Biomedical, Inc. (AMEX:IBO) stock is trading higher Monday after the company announced a limited merger and share exchan...

Core News & Articles

Key Transaction TermsUnder the terms of the Merger Agreement, a merger subsidiary incorporated in Nevada as a PubCo subsidiary ...

Core News & Articles

Dr Ashleys Limited, a Hong Kong based global pharmaceutical company ("Dr Ashleys"), and Impact BioMedical Inc. ("Im...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION